Cassava Sciences Inc’s filing revealed that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0 on Nov 29 ’24. In the deal valued at $3.87 per share,4,000 shares were sold. As a result of this transaction, Kupiec James William now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Schoen Eric sold 59,800 shares, generating $230,828 in total proceeds. Upon selling the shares at $3.86, the Chief Financial Officer now owns 11,500 shares.
Before that, Schoen Eric sold 2,000 shares. Cassava Sciences Inc shares valued at $7,640 were divested by the Chief Financial Officer at a price of $3.82 per share. As a result of the transaction, Schoen Eric now holds 0 shares, worth roughly $0.0.
H.C. Wainwright downgraded its Cassava Sciences Inc [SAVA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in early October from “a Neutral” to “a Buy”. H.C. Wainwright also remained covering SAVA and has decreased its forecast on July 01, 2024 with a “Neutral” recommendation from previously “Buy” rating. B. Riley Securities revised its rating on November 16, 2022. It rated SAVA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of SAVA
On Tuesday, Cassava Sciences Inc [NASDAQ:SAVA] saw its stock fall -4.14% to $2.55. Over the last five days, the stock has lost -11.76%. Cassava Sciences Inc shares have fallen nearly -88.67% since the year began. Nevertheless, the stocks have fallen -91.36% over the past one year. While a 52-week high of $42.20 was reached on 08/05/24, a 52-week low of $2.64 was recorded on 12/17/24. SMA at 50 days reached $19.37, while 200 days put it at $21.36.
Levels Of Support And Resistance For SAVA Stock
The 24-hour chart illustrates a support level at 2.50, which if violated will result in even more drops to 2.45. On the upside, there is a resistance level at 2.65. A further resistance level may holdings at 2.75. The Relative Strength Index (RSI) on the 14-day chart is 22.86, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 100.00%. Stochastics %K at 1.36% indicates the stock is a buying.
How much short interest is there in Cassava Sciences Inc?
A steep rise in short interest was recorded in Cassava Sciences Inc stocks on 2024-11-29, dropping by -1.41 million shares to a total of 17.16 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 18.57 million shares. There was a decline of -8.21%, which implies that there is a negative sentiment for the stock.
